首页> 美国卫生研究院文献>OncoTargets and therapy >Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

【2h】

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

机译：双皮质素样激酶1与前列腺癌的肿瘤侵袭性和较差的无生化复发生存率相关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundDoublecortin-like kinase 1 (DCLK1) has been proven to be involved in numerous tumors, while its role in prostate cancer (PCa) is still unclear. This study aimed at investigating the expression pattern and prognostic value of DCLK1 in PCa.

机译：背景：双皮质素样激酶1（DCLK1）已被证明参与多种肿瘤，但其在前列腺癌（PCa）中的作用尚不清楚。这项研究旨在调查DCLK1在PCa中的表达模式和预后价值。

著录项

期刊名称 OncoTargets and therapy
作者
Donggen Jiang; Chutian Xiao; Tuzeng Xian; Liantao Wang; Yunhua Mao; Junfu Zhang; Jun Pang;
展开▼
作者单位

展开▼
年(卷),期 2018(11),-1
年度 2018
页码 1077–1086
总页数 10
原文格式 PDF
正文语种
中图分类应用微生物学;肿瘤学;
关键词
prostatic neoplasm DCLK1 BCR prognosis radical prostatectomy biomarker;

机译：前列腺肿瘤;DCLK1;BCR;预后;前列腺癌根治术;生物标志物;

相似文献

外文文献
中文文献
专利

1. Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer [J] . Donggen Jiang, Chutian Xiao, Tuzeng Xian, OncoTargets and therapy . 2018,第2期

机译：双峰样激酶1与肿瘤侵袭性和前列腺癌中没有差的生物化学复发生存
2. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer [J] . Zhi Cao, Yalong Xu, Fei Guo, Disease markers . 2020,第2a3期

机译：Fasn蛋白过表达表明前列腺癌中的无生物化复发生存率差
3. Decreased expression of myosin light chain MYL9 in stroma predicts malignant progression and poor biochemical recurrence-free survival in prostate cancer [J] . HuangY.-Q., HanZ.-D., LiangY.-X., Medical oncology . 2014,第1期

机译：基质中肌球蛋白轻链MYL9的表达减少预示着前列腺癌的恶性进展和不良的无生化复发的生存
4. Association between tumor heterogeneity and progression-free survival in non-small cell lung cancer patients with EGFR mutations undergoing tyrosine kinase inhibitors therapy [C] . Jiangdian Song, Di Dong, Yanqi Huang, Annual International Conference of the IEEE Engineering in Medicine and Biology Society . 2016

机译：接受酪氨酸激酶抑制剂治疗的EGFR突变非小细胞肺癌患者肿瘤异质性与无进展生存的关系
5. Evaluation of the association between quality of life, physical function, and comorbid conditions with survival in prostate cancer patients in CaPSURE(TM) (Cancer of the Prostate Strategic Urologic Research Endeavor) registry. [D] . Sadetsky, Natalia. 2009

机译：在CaPSURE™（前列腺癌战略性泌尿外科研究努力癌症）登记册中评估前列腺癌患者的生活质量，身体功能和合并症与生存之间的关联。
6. FASN Protein Overexpression Indicates Poor Biochemical Recurrence-Free Survival in Prostate Cancer [O] . Zhi Cao, Yalong Xu, Fei Guo, 2020

机译：Fasn蛋白过表达表明前列腺癌中的无生物化复发生存率差
7. High BIRC7 Expression Might Be an Independent Prognostic Indicator of Poor Recurrence-Free Survival in Patients With Prostate Cancer [O] . Yi Yang, Peng Sun, Wei Xu, 2018

机译：高BIRC7表达可能是前列腺癌患者的无急性存活的独立预后指标

Association of doublecortin-like kinase 1 with tumor aggressiveness and poor biochemical recurrence-free survival in prostate cancer

摘要

著录项

相似文献

相关主题

期刊订阅